September 27, 2022
The Third Circuit declined Tuesday to reconsider its decision backing $1 million in penalties imposed against a former pharmaceutical CEO for failing to report his Swiss bank accounts.
September 06, 2022
A former pharmaceutical CEO asked the full Third Circuit on Tuesday to rethink a three-judge panel's affirmation of $1 million in penalties imposed against him for failing to report his Swiss bank accounts.
July 22, 2022
A former pharmaceutical CEO faces almost $1 million in penalties for failing to report his Swiss bank accounts after a Third Circuit panel Friday affirmed a lower court ruling that his omission was willful.
March 02, 2022
A Third Circuit panel seemed wary Wednesday of the U.S. government's use of a UBS document to prove the validity of its foreign bank account reporting penalty calculation against an ex-pharmaceutical executive, saying the record's connection to him is unclear.
February 28, 2022
The Third Circuit's March argument schedule has panels digging into arbitration matters surrounding a National Football League agent's poaching row and contract claims against a pharmacy benefit manager, as well as probing a third-party agreement that sank an overtime suit by energy inspectors.
November 09, 2021
The Third Circuit should overturn a lower court award of over $1 million in penalties against a former pharmaceutical CEO because the U.S. government failed to show he willfully failed to report his foreign bank accounts, he told the court.
October 18, 2021
The U.S. government urged the Third Circuit against revisiting a former pharmaceutical executive's dispute over $1 million in penalties for failing to report an offshore bank account, arguing that a district court correctly found his conduct was willful.